Insulin Delivery Systems

Insulin Delivery Systems

Global Insulin Delivery Systems Market to Reach US$16.8 Billion by 2030

The global market for Insulin Delivery Systems estimated at US$13.4 Billion in the year 2023, is expected to reach US$16.8 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2023-2030. Syringes, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$7.0 Billion by the end of the analysis period. Growth in the Pens segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.6 Billion While China is Forecast to Grow at 5.8% CAGR

The Insulin Delivery Systems market in the U.S. is estimated at US$3.6 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2030 trailing a CAGR of 5.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.6% and 4.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.4% CAGR.

Insulin Delivery Systems - Key Trends and Drivers

Insulin delivery systems are a critical component in the management of diabetes, a chronic condition affecting millions of people worldwide. These systems are designed to administer insulin, a hormone necessary for regulating blood glucose levels, in a controlled and efficient manner. There are various types of insulin delivery systems, including syringes, insulin pens, insulin pumps, and newer methods like inhalable insulin. Each of these systems offers different advantages in terms of convenience, precision, and user experience. Insulin pens, for example, are prefilled and easy to carry, making them a popular choice for many patients. Insulin pumps provide continuous insulin delivery, closely mimicking the body’s natural insulin release, which is particularly beneficial for individuals with type 1 diabetes. The landscape of insulin delivery systems is continuously evolving, driven by advancements in medical technology and a deeper understanding of patient needs.

Technological innovation has been a significant driver in the advancement of insulin delivery systems. Modern insulin pumps are now equipped with advanced features such as continuous glucose monitoring (CGM) integration, automated insulin delivery (AID), and smartphone connectivity. These advancements allow for more precise and personalized diabetes management, reducing the risk of hypoglycemia and improving overall glycemic control. Additionally, the development of smart insulin pens, which can track doses and provide reminders, is helping to address issues related to adherence and dosing accuracy. The introduction of inhalable insulin offers a non-invasive alternative to injections, appealing to patients who are needle-averse. Furthermore, research into closed-loop systems, also known as artificial pancreas systems, is ongoing, with the goal of creating fully automated insulin delivery solutions that require minimal patient intervention. These innovations are not only improving the quality of life for diabetes patients but are also setting new standards in diabetes care.

The growth in the insulin delivery systems market is driven by several factors, including the increasing prevalence of diabetes, technological advancements, and a growing awareness of diabetes management. The rising incidence of diabetes particularly type 2 diabetes, due to factors such as obesity and sedentary lifestyles, has significantly expanded the demand for efficient and user-friendly insulin delivery solutions. Technological advancements have made these systems more accessible and effective, attracting a broader patient base. The integration of digital health technologies, such as mobile apps and cloud-based data management, is enhancing patient engagement and adherence to treatment protocols. Consumer behavior is also shifting, with a greater emphasis on convenience and minimally invasive options, driving the adoption of innovative delivery methods like smart pens and inhalable insulin. Additionally, supportive government policies and initiatives aimed at improving diabetes care infrastructure are facilitating market growth. The competitive landscape is marked by collaborations between tech companies and healthcare providers, further accelerating innovation and market penetration. Overall, the insulin delivery systems market is poised for significant expansion, propelled by a combination of demographic trends, technological progress, and evolving patient preferences.

Select Competitors (Total 32 Featured) -
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Insulet Corporation
  • Medtronic, Inc.
  • Novo Nordisk A/S
  • Wockhardt Ltd.
  • Ypsomed AG
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Global Economic Update
Insulin Delivery Systems - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Prevalence of Diabetes Throws the Spotlight on Insulin Delivery Systems
Technological Advancements Propel Growth in Smart Insulin Delivery Devices
Increasing Adoption of Continuous Glucose Monitoring (CGM) Systems Expands Addressable Market Opportunity
Integration of Digital Health Technologies Strengthens Business Case for Advanced Insulin Delivery Solutions
Development of Automated Insulin Delivery (AID) Systems Boost Innovation
Non-Invasive Delivery Methods, Such as Inhalable Insulin, Drive Adoption among Needle-Averse Patients
Enhanced Smartphone Connectivity and Mobile App Integration Spurs Growth in User Engagement
Personalized Diabetes Management Generates Demand for Customized Insulin Delivery Solutions
Research into Closed-Loop Systems and Artificial Pancreas Technology Throws the Spotlight on Future Trends
Increased Focus on Minimally Invasive Options Expands Addressable Market Opportunity
Consumer Shift towards Convenience and Ease of Use Drives Adoption of Innovative Insulin Delivery Methods
Enhanced Data Management and Cloud-Based Solutions Generates Demand for Integrated Insulin Delivery Systems
Rising Incidence of Type 2 Diabetes among Younger Populations Influences Market Dynamics
Improving Quality of Life for Diabetes Patients Sustains Growth in Advanced Insulin Delivery Technologies
Evolution of Smart Insulin Pens and Dose Tracking Technologies Strengthens Business Case for Precision Medicine
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Insulin Delivery Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Insulin Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Pens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Pen needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Pen needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Pen needles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Jet Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Homecare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Homecare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Homecare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Ambulatory Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 30: World Historic Review for Ambulatory Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: World 16-Year Perspective for Ambulatory Care Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 32: USA Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 33: USA Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: USA 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 35: USA Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: USA Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: USA 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
CANADA
TABLE 38: Canada Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: Canada Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: Canada 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 41: Canada Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: Canada Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: Canada 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
JAPAN
Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 44: Japan Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Japan Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: Japan 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 47: Japan Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Japan Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Japan 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
CHINA
Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 50: China Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: China Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: China 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 53: China Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: China Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: China 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
EUROPE
Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 56: Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 57: Europe Historic Review for Insulin Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Europe 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 59: Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: Europe Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: Europe 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 62: Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: Europe Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: Europe 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
FRANCE
Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 65: France Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: France Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: France 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 68: France Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: France Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: France 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
GERMANY
Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 71: Germany Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: Germany Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: Germany 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 74: Germany Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Germany Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Germany 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
ITALY
TABLE 77: Italy Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Italy Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Italy 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 80: Italy Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Italy Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Italy 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
UNITED KINGDOM
Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 83: UK Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: UK Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: UK 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 86: UK Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: UK Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: UK 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
SPAIN
TABLE 89: Spain Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: Spain Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Spain 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 92: Spain Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Spain Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Spain 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
RUSSIA
TABLE 95: Russia Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Russia Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Russia 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 98: Russia Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Russia Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Russia 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Rest of Europe Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Rest of Europe 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Rest of Europe Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Rest of Europe 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 108: Asia-Pacific Historic Review for Insulin Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: Asia-Pacific Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: Asia-Pacific Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
AUSTRALIA
Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 116: Australia Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: Australia Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: Australia 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 119: Australia Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: Australia Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: Australia 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
INDIA
Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 122: India Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: India Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: India 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 125: India Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: India Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: India 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 128: South Korea Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: South Korea Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: South Korea 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 131: South Korea Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: South Korea Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: South Korea 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Rest of Asia-Pacific Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Rest of Asia-Pacific Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
LATIN AMERICA
Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 140: Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 141: Latin America Historic Review for Insulin Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Latin America 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 143: Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Latin America Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Latin America 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 146: Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 147: Latin America Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Latin America 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 149: Argentina Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 150: Argentina Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 151: Argentina 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 152: Argentina Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 153: Argentina Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 154: Argentina 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
BRAZIL
TABLE 155: Brazil Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 156: Brazil Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 157: Brazil 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 158: Brazil Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 159: Brazil Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 160: Brazil 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
MEXICO
TABLE 161: Mexico Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 162: Mexico Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 163: Mexico 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 164: Mexico Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 165: Mexico Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 166: Mexico 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 168: Rest of Latin America Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 169: Rest of Latin America 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 171: Rest of Latin America Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 172: Rest of Latin America 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
MIDDLE EAST
Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 173: Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 174: Middle East Historic Review for Insulin Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 175: Middle East 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 176: Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 177: Middle East Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 178: Middle East 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 179: Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 180: Middle East Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 181: Middle East 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
IRAN
TABLE 182: Iran Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 183: Iran Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 184: Iran 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 185: Iran Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 186: Iran Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 187: Iran 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
ISRAEL
TABLE 188: Israel Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 189: Israel Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 190: Israel 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 191: Israel Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 192: Israel Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 193: Israel 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 195: Saudi Arabia Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 196: Saudi Arabia 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 198: Saudi Arabia Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 199: Saudi Arabia 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 200: UAE Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 201: UAE Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 202: UAE 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 203: UAE Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 204: UAE Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 205: UAE 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 207: Rest of Middle East Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 208: Rest of Middle East 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 210: Rest of Middle East Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 211: Rest of Middle East 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
AFRICA
Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 212: Africa Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 213: Africa Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 214: Africa 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
TABLE 215: Africa Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 216: Africa Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 217: Africa 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings